Sign In
Buy MCRB
$4.83
+0.0500 (+1.05%)
At Close: Jul 31, 2026
Rhône-Alpes : comment ces 25 patrons continuent d'embaucher
08:56am, Thursday, 06'th Aug 2020
Capital a sondé pour vous les entreprises de la région Rhône-Alpes. En voici 25 qui, après avoir souvent adapté leur activité pendant le confinement, envisagent la reprise de leur développement
Seres Therapeutics Inc (NASDAQ:MCRB) Holdings Cut by Sumitomo Mitsui Trust Holdings Inc.
05:26am, Monday, 03'rd Aug 2020
Sumitomo Mitsui Trust Holdings Inc. decreased its stake in Seres Therapeutics Inc (NASDAQ:MCRB) by 12.1% in the second quarter, according to the company in its most recent filing with the Securities &
Seres Therapeutics (NASDAQ:MCRB) Downgraded by Zacks Investment Research
01:42am, Monday, 03'rd Aug 2020
Zacks Investment Research downgraded shares of Seres Therapeutics (NASDAQ:MCRB) from a buy rating to a sell rating in a research note released on Thursday, Zacks.com reports. According to Zacks, “Se
Research Analysts Offer Predictions for Seres Therapeutics Inc’s FY2020 Earnings (NASDAQ:MCRB)
02:14am, Sunday, 02'nd Aug 2020
Seres Therapeutics Inc (NASDAQ:MCRB) – Stock analysts at Jefferies Financial Group issued their FY2020 earnings estimates for Seres Therapeutics in a research note issued on Tuesday, July 28th. Jeff
Janus Henderson : Dividend/Distribution - JHG | MarketScreener
08:16am, Wednesday, 29'th Jul 2020Comment rédiger un CDI ?
08:12am, Wednesday, 29'th Jul 2020
La conclusion d’un contrat de travail à durée indéterminée demeure la forme typique et générale de la relation de travail.,
A cet égard, la rédaction d’un contrat de travail à durée ind
Earnings Preview: Seres Therapeutics (MCRB) Q2 Earnings Expected to Decline
04:33pm, Tuesday, 28'th Jul 2020
Seres Therapeutics (MCRB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Recap: Seres Therapeutics Q2 Earnings
01:41pm, Tuesday, 28'th Jul 2020
Shares of Seres Therapeutics (NASDAQ:MCRB) fell 6.4% after the company reported Q2 results.Quarterly Results Earnings per share decreased 16.67% over the past year to ($0.28), which missed the estimat
Seres Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates
11:00am, Tuesday, 28'th Jul 2020
Topline data from SER-109 Phase 3 study in recurrent C. difficile infection expected in August 2020; pipeline of other promising candidates advancing.
How are the Stock Market, Earthquakes, and Disease Related?
12:10am, Tuesday, 28'th Jul 2020
Predicting the spread of infections using time series data, with techniques traditionally applied to model financial trends
Debêntures: aprenda como investir nesses títulos de renda fixa
02:32am, Monday, 27'th Jul 2020
As debêntures títulos de renda fixa de crédito privado que normalmente possuem maior rentabilidade. Clique e saiba como investir em debêntures.
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
Chute «historique» des embauches au second trimestre en France
09:23am, Wednesday, 22'nd Jul 2020
Après plusieurs mois de baisse spectaculaire, les embauches se reprennent en mai et juin. Le bilan du trimestre reste inquiétant.
En quoi va consister l'aide à l'embauche des jeunes promise par le gouvernement ?
09:16am, Tuesday, 21'st Jul 2020
Jusqu'ici, la piste privilégiée était une « exonération de charges » salariales mais il n'est pas exclu que l'aide prenne finalement la forme d'une prime. En baissant le coût du travail, l'ex
Apesar da Selic em piso histórico, gestoras de multimercados resistem a reduzir famosa taxa "2% com 20%"
08:24pm, Monday, 20'th Jul 2020
Levantamento revela que apenas dois de 76 fundos reduziram a cobrança durante o primeiro semestre de 2020
